NephroBlog: Pruritus and Hemodialysis

In BMC Nephrology, an article by Daraghmeh et al. examines pruritus among hemodialysis patients and its effects on sleep quality. In this BMC Nephrology post, Editor Dr. Daphne Knicely will discuss the extent of the problem and possible treatments.
NephroBlog: Pruritus and Hemodialysis
Like

Share this post

Choose a social network to share with, or copy the URL to share elsewhere

This is a representation of how your post may appear on social media. The actual post will vary between social networks

Explore the Research

BioMed Central
BioMed Central BioMed Central

Prevalence of pruritus associated with hemodialysis and its association with sleep quality among hemodialysis patients: a multicenter study - BMC Nephrology

Background CKD-associated pruritus (chronic kidney disease-associated pruritus) is one of the common symptoms in hemodialysis patients, with a major effect on sleep quality because it occurs at night. The main objective of this study is to determine the prevalence of pruritus among hemodialysis (HD) patients and its impact on sleep and investigate factors associated with pruritus and sleep quality. Methods A cross-sectional study began in January until March of 2021 in HD centers of four different hospitals in the West Bank, Palestine. Patients with HD aged 18 years or older were included in our investigation. Pruritus and sleep problems were assessed by a 5-D itching score and the Pittsburgh Sleep Quality Index (PSQI) score. Results Of 280 HD patients, 250 were accepted to participate in our study. The mean age of the participants was (54.9 ± 15.08). 62.8% were male, and 42.4% of the participants were elderly (age ≥ 60yrs). Pruritus was observed in 121 (48.4%). The 5-D itching score had a median [IQR] of 5.0[5.0–15.0], and 57.2% had a score ≥ 6 points. Severe pruritus was reported in 28.1% of patients. The score was significantly associated with residency (p = 0.033) and chronic comorbidities (p = 0.026). The PSQI score has a median [IQR] of 8[5–12], and 66.4% are poor sleepers with a score of < 5. The score was significantly associated with age (p = 0.017), marital status (p = 0.022), occupational status (p = 0.007), chronic comorbidities (p > 0.001), chronic medication (p = 0.008), severity of pruritus (p = 0.003) and duration of pruritus (p = 0.003). Regression analysis showed that the 5-D itching score and the total number of comorbidities were significantly associated with the PSQI score. Conclusions Pruritus is a widespread complication among HD patients in Palestine. Pruritus also has major effects on sleep quality and is associated with poor sleep quality.

Patients with end-stage kidney disease on hemodialysis can have many different symptoms that affect their quality of life.  While seeing patients in the dialysis unit, I often see many similar symptom complaints from patients.  Complaints from patients on hemodialysis include post-dialysis fatigue (need to take a nap after dialysis, no energy to run errands, etc.), muscle cramps (at night, right after   dialysis), and pruritus.  Pruritus is the medical term for itchy skin that can affect the quality of life of a person. The pathophysiology of chronic kidney disease-associated pruritus (also known as hemodialysis-associated pruritus or uremic pruritus) is thought to be multifactorial: a combination of demographic, biologic, neuropathic, and psychogenic factors.  One theory suggest interleukin-1 as a biological causes of pruritus.  The pruritus is often worse at night and affects sleep quality in these patients. 

 Daraghmeh et al. published a cross-sectional study examining pruritus and sleep problems among hemodialysis patients in four different centers in Palestine.  Using the 5-D itching score for pruritis and the Pittsburgh Sleep Quality Index (PSQI) score for sleep disturbances.  Of the 250 participants, there were 121 with complaints of pruritus and 21% patients with severe symptoms.  About 66% were classified as poor sleepers on the PSQI.  Regression analysis showed that the 5-D itching score and the total number of comorbidities were significantly associated with the PSQI score, demonstrating that poor sleep quality is often due to pruritus. 

A prior publication by Orasan et al. found that pruritus and poor sleep quality can significantly affect survival in this population.  Survival differences were found in the 170 patients treated with hemodialysis or hemodiafiltration subdivided as having  both pruritus/insomnia, pruritus alone, insomnia alone, or neither symptom.  Survival at 20 months was lower in those patients with both pruritus and insomnia, highlighting that these symptoms are beyond a minor annoyance. 

Takahashi et al. reported on development of a treatment algorithm using topical medications for pruritus that has shown effective results.  The proportion of patients with pruritus decreased significantly from 96.6% in 2009 to 66.8% in 2018 with the use of this algorithm.  The algorithm consisted of treatment with moisturizers alone; moisturizer and topical steroids; moisturizer, topical steroids and Nalfurafine; and moisturizer and Nalfurafine.  Nalfurafine, which can be intravenous or orally administered, is a kappa opioid receptor agonist but unfortunately it is not available in the all countries.  A newer agent,  Difelikefalin, also a kappa opioid receptor agonist is showing promise.  This medication is administered into the venous line of the dialysis circuit at each hemodialysis session. 

Use of moisturizers applied several times a day is an important part of pruritus treatment. If there is no relief, adding a topical steroid or the addition of antihistamines, or agents to address neuropathy such as gabapentin or pregabalin are potential next steps.  With the emergence of new medications like Difelikefalin this opens the door to some potentially better treatment algorithms. 

The incessant itching does not just effect our patient’s quality of life but also their risk of survival. What is your treatment algorithm for chronic kidney disease-associated pruritus?


- Dr. Daphne Knicely

BMC Nephrology

Please sign in or register for FREE

If you are a registered user on Research Communities by Springer Nature, please sign in

Follow the Topic

Nephrology
Life Sciences > Health Sciences > Clinical Medicine > Nephrology
Pruritus
Life Sciences > Health Sciences > Clinical Medicine > Diagnosis > Clinical Signs and Symptoms > Pruritus
Chronic Kidney Disease
Life Sciences > Health Sciences > Clinical Medicine > Diseases > Kidney Diseases > Chronic Kidney Disease
  • BMC Nephrology BMC Nephrology

    This is an open access journal publishing original peer-reviewed research articles in all aspects of the prevention, diagnosis and management of kidney and associated disorders, as well as related molecular genetics, pathophysiology, and epidemiology.

Related Collections

With Collections, you can get published faster and increase your visibility.

Risk stratification through AI application in kidney care

The increasing global burden of chronic kidney disease (CKD) necessitates an ongoing exploration of innovative strategies to enhance patient management and optimise healthcare delivery. Artificial Intelligence (AI) offers unprecedented opportunities for risk stratification in kidney care, harnessing vast datasets to inform clinical decision-making, improve patient outcomes, and drive efficiencies in healthcare systems.

AI-based CKD progression prediction models leverage machine learning algorithms to analyse patient data, enabling healthcare professionals to identify individuals at heightened risk of disease progression. These tools have been validated in various clinical settings and demonstrate considerable potential in personalising patient care.

Machine learning risk scoring for dialysis initiation has emerged as a vital resource, improving decision-making processes by facilitating timely interventions. Predictive analytics for transplant eligibility ensure that patients receive the most suitable and timely interventions based on their unique health profiles. This algorithmic stratification of renal patient cohorts allows for a more nuanced understanding of patient needs, moving us beyond a one-size-fits-all approach to a model that emphasises individualised care.

The potential of AI in risk stratification encompasses the broad spectrum of healthcare delivery, influencing policy formulation, resource allocation, and patient education. By continuing to expand our collective understanding in this area, we can foster an environment where AI-driven innovations are systematically integrated into kidney care protocols.

Topics of interest include but are not limited to:

  • AI-based CKD progression prediction
  • Machine learning risk scoring for dialysis initiation
  • Predictive analytics for transplant eligibility
  • Algorithmic stratification of renal patient cohorts
  • Personalised nephrology risk models
  • Integration of social determinants in risk assessment
  • Impact of AI on patient engagement and outcomes
  • Interoperability challenges and solutions in kidney care

We welcome submissions employing AI and Machine Learning approaches, as well prediction models that use regression or machine learning methods. We recommend adhering to TRIPOD guidelines for reporting clinical prediction models that use regression or machine learning methods.

We encourage authors to share accompanying data. According to our policies, submission of a manuscript to a BMC journal implies that materials described in the manuscript, including all relevant raw data, will be freely available to any scientist wishing to use them for non-commercial purposes, without breaching participant confidentiality. We require data deposition for some data types. Further information can be found in our policies.

This Collection supports and amplifies research related to SDG 3: Good Health and Well-being.

All manuscripts submitted to this journal, including those submitted to collections and special issues, are assessed in line with our editorial policies and the journal’s peer review process. Reviewers and editors are required to declare competing interests and can be excluded from the peer review process if a competing interest exists.

Publishing Model: Open Access

Deadline: Mar 19, 2027

Mental health integration in nephrology

The intersection of mental health and nephrology is gaining increasing recognition as a critical component of integrated patient care. Chronic kidney disease (CKD), along with treatments such as dialysis and kidney transplantation, is frequently associated with significant psychological distress, leading to poorer health outcomes. This Collection aims to explore the integration of mental health support within nephrology practices, addressing how psychological factors influence disease management and patient quality of life.

Recent advances in this field include the implementation of routine depression screening in dialysis settings and the development of integrated behavioral health models within nephrology clinics. These strategies have shown promise in addressing the psychological needs of patients and their family caregivers, fostering better adherence to treatment regimens, and ultimately improving physical and mental well-being among this population.

We welcome submissions including original research, reviews, and implementation studies. Topics of interest include, but are not limited to:

  • Psychological support in CKD
  • Depression screening in dialysis and transplant patients
  • Integrated behavioral health in nephrology care
  • Cognitive and behavioral interventions in CKD management
  • Digital mental health interventions in nephrology
  • Dyadic and family-based interventions in CKD management

This Collection supports and amplifies research related to SDG 3: Good Health and Well-being

All manuscripts submitted to this journal, including those submitted to collections and special issues, are assessed in line with our editorial policies and the journal’s peer review process. Reviewers and editors are required to declare competing interests and can be excluded from the peer review process if a competing interest exists.

Publishing Model: Open Access

Deadline: Jan 30, 2027